Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.58

+0.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (10019)	1/14/2004 2:37:20 PM
From: zeta1961	Read Replies (1) of 52153

Thanks Peter...will do more DD...I am a newbie investor and have focused primarily in cancer biotechs and know infectious disease biotechs on a cursory level... Have you looked at SCLN?...hepC and B...has been suffering a setback in pps due to no news of late...in P3's for adjunct for HepC which is already approved in Japan and selling in S. America(Mexico) and other foreign countries...some Americans are buying it from them...also a very competitive area! Regards, Zeta

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next